Marc D Beer

CIK 1314575 · View on SEC EDGAR ↗

Insider

First SEC filing: June 10, 2026 · Latest: June 10, 2026

On this page

Insider at

Insider transactions

2 buys (P) 0 sells (S) Net: $202,204 + 28 non-open-market transactions below Avg return of open purchases vs now: -12.3% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

28 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 11, 2026 BTMD P 16,000 $1.55 $24,800 239,744 Direct +7.15% Acquired -12.9% (price as of 2026-08-19)
Aug. 10, 2026 BTMD P 115,950 $1.53 $177,404 223,744 Direct +107.57% Acquired -11.8% (price as of 2026-08-19)
Jan. 9, 2023 BTMD S 865,384 $3.00 $2,596,152 0 Direct -100.00% Disposed -55.0% (price as of 2026-08-19)
March 20, 2017 NERV P 25,000 $7.89 $197,250 50,000 Direct +100.00% Acquired -92.2% (price as of 2026-08-19)
March 17, 2017 NERV P 25,000 $8.34 $208,500 25,000 Direct — Acquired -92.6% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 8, 2026 BTMD Employee Stock Option (Right to Buy) Class A Common Stock (114,157) $2.34 June 7, 2036 114,157 Acquired
May 12, 2026 BTMD Stock Option (Right to Buy) Class A Common Stock (195,000) $2.20 May 11, 2036 195,000 Acquired
Jan. 6, 2023 BTMD Retained Biote Units Class A Common Stock (865,384) — — 865,384 Disposed
Nov. 15, 2022 BTMD Stock Option (Right to Buy) Class A Common Stock (477,721) $3.97 Nov. 14, 2032 477,721 Acquired
Nov. 15, 2022 BTMD Stock Option (Right to Buy) Class A Common Stock (477,721) $4.04 Nov. 14, 2032 477,721 Acquired
May 26, 2022 BTMD Retained Biote Units Class A Common Stock (654,387) — — 654,387 Acquired
May 26, 2022 BTMD Retained Biote Units Class A Common Stock (654,387) — — 654,387 Acquired
May 26, 2022 BTMD Retained Biote Units Class A Common Stock (3,178,089) — — 3,178,089 Acquired
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (80,356) $9.49 Dec. 19, 2023 80,356 Disposed
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (12,500) $10.20 Jan. 31, 2020 12,500 Acquired
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (12,500) $10.00 May 31, 2027 12,500 Disposed
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (12,500) $10.00 Jan. 31, 2020 12,500 Acquired
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (12,500) $10.20 June 15, 2026 12,500 Disposed
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (7,500) $4.34 Jan. 31, 2020 7,500 Acquired
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (7,500) $4.34 Feb. 1, 2025 7,500 Disposed
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (127,513) $6.00 Jan. 31, 2020 127,513 Acquired
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (127,513) $6.00 June 29, 2024 127,513 Disposed
Jan. 31, 2018 NERV Stock Option (Right to Buy) Common Stock (80,356) $9.49 Jan. 31, 2020 80,356 Acquired
June 1, 2017 NERV Stock Option (Right to Buy) Common Stock (12,500) $10.00 May 31, 2027 12,500 Acquired
June 16, 2016 NERV Stock Option (right to buy) Common Stock (12,500) $10.20 June 15, 2026 12,500 Acquired
Feb. 2, 2015 NERV Stock Option (right to buy) Common Stock (7,500) — Feb. 1, 2025 7,500 Acquired
Feb. 2, 2015 NERV Stock Option (right to buy) Common Stock (7,500) — Feb. 1, 2015 7,500 Acquired
June 30, 2014 NERV Stock Option (Right to Buy) Common Stock (127,513) $6.00 June 29, 2024 127,513 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Sept. 26, 2014 NERV Stock Option (right to buy)→ Common Stock — Direct
June 30, 2014 NERV Stock Option (right to buy)→ Common Stock (60,267) 60,267 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BTMD

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $156,934 — — — $104,418 — $42,500 $1,406,783
2024 $433,052 — — — $261,114 — $413 $2,675,601

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.